← Eichor
Condition: Nanoparticles Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nanoparticles

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Phase 3 · 9 location(s) · Uppsala University · NCT04722692Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
Phase 2 · 1 location(s) · Daihong Liu · NCT07321301Biomarkers for Monitoring Dementia Progression
Phase N/A · 2 location(s) · IRCCS San Raffaele Roma · NCT06855368Effect of Onion Extract Nanoparticle Gel Phonophoresis on Postsurgical Scar of Cesarean Section.
NA · 2 location(s) · October 6 University · NCT06658444Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1 · 10 location(s) · Epitopea Ltd · NCT07665515A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
Phase 3 · 1 location(s) · Second Affiliated Hospital of Xi'an Jiaotong University · NCT06791005Antimicrobial Photodynamic Therapy With ICG-Loaded Nanoparticles for Periodontitis Management
Phase 2 · 1 location(s) · Nada Mahmoud Soliman · NCT07316023CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
EARLY_Phase 1 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT07371767Pilot Study of AuTNA I
NA · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT05853107Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
Phase N/A · 1 location(s) · Vastra Gotaland Region · NCT06104371Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing So
Phase 1 · 7 location(s) · Myeloid Therapeutics · NCT07334119NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
NA · 1 location(s) · Poznan University of Medical Sciences · NCT06271421Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
EARLY_Phase 1 · 1 location(s) · Ruijin Hospital · NCT06577532Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
NA · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06529913Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Phase 1/Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT04789486Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658Extracorporeal Shockwave Versus Phonophoresis Using Chitosan-Nanoparticles Gel on Functional and Anatomical Changes Dete
NA · 2 location(s) · Cairo University · NCT06567301Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Phase 1 · 6 location(s) · Myeloid Therapeutics · NCT05969041CS-121 APOC3 Base Editing in FCS
EARLY_Phase 1 · 1 location(s) · CorrectSequence Therapeutics Co., Ltd · NCT07176923Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Phase 1/Phase 2 · 17 location(s) · Genprex, Inc. · NCT05703971A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059)
EARLY_Phase 1 · 1 location(s) · The First Affiliated Hospital of Henan University of Science · NCT07347080Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients
Phase 2 · 1 location(s) · Vastra Gotaland Region · NCT06169072Phase 1/2 Study of UI-102 in Selected Advanced Cancers
Phase 1/Phase 2 · 3 location(s) · United Immunity, co., Ltd. · NCT07605962A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172Evaluation of Doxycycline Nanoparticle With Gelatin Sponge on Immediate Implant in Esthetic Region
NA · 1 location(s) · Kafrelsheikh University · NCT06809829Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Phase N/A · 7 location(s) · Alnylam Pharmaceuticals · NCT05040373Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
NA · 1 location(s) · Fondazione Policlinico Universitario Campus Bio-Medico · NCT07659639Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Phase 1/Phase 2 · 10 location(s) · Genprex, Inc. · NCT04486833Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
Phase 1 · 1 location(s) · HDT Bio · NCT06799013
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.